{"id":53225,"date":"2024-08-20T13:49:45","date_gmt":"2024-08-20T13:49:45","guid":{"rendered":"https:\/?p=53225"},"modified":"2024-08-20T13:49:45","modified_gmt":"2024-08-20T13:49:45","slug":"medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/","title":{"rendered":"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches"},"content":{"rendered":"<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/MDT\">Medtronic PLC (MDT)<\/a>, a global leader in healthcare technology, recently released its first-quarter financial results for fiscal year 2025 (FY25). The company reported promising growth, driven by product innovation across its diversified health tech portfolio.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Key Insights from Medtronic PLC Q1 Reports:\u00a0<\/strong><\/h2>\n<p>Below are the key points from Medtronic&#8217;s Q1 2025 earning.<\/p>\n<ul>\n<li><span style=\"font-weight: 400;\"><strong>Q1 FY25 Revenue<\/strong>: Medtronic reported $7.915 billion in revenue, with adjusted revenue at $8.004 billion, reflecting a 2.8% increase as reported and a 5.3% increase on an organic basis.<\/span><\/li>\n<li><span style=\"font-weight: 400;\"><strong>EPS Performance:<\/strong> GAAP diluted EPS rose by 36% to $0.80, while non-GAAP diluted EPS increased by 3% to $1.23.<\/span><\/li>\n<li><span style=\"font-weight: 400;\"><strong>Cardiovascular Portfolio:<\/strong> This segment saw a 5.5% revenue increase as reported, with organic growth at 6.9%, driven by strong performance in Cardiac Rhythm &amp; Heart Failure and Structural Heart &amp; Aortic divisions.<\/span><\/li>\n<li><span style=\"font-weight: 400;\"><strong>Neuroscience Portfolio:<\/strong> Reported revenue increased by 4.4%, with organic growth of 5.3%, highlighting solid performance across the portfolio.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\"> <a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/MDT\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-53227 size-full\" src=\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/08\/sta-stock-chart-widget-2024-08-20T184018.128.png\" alt=\"\" width=\"494\" height=\"593\" srcset=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/08\/sta-stock-chart-widget-2024-08-20T184018.128.png 494w, https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/08\/sta-stock-chart-widget-2024-08-20T184018.128-250x300.png 250w, https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/08\/sta-stock-chart-widget-2024-08-20T184018.128-125x150.png 125w\" sizes=\"(max-width: 494px) 85vw, 494px\" \/><\/a>\u00a0<\/span><\/p>\n<h2><strong>Stock Target Advisor&#8217;s Analysis on Medtronic PLC:\u00a0<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">According to <a href=\"https:\/\/www.stocktargetadvisor.com\/\">Stock Target Advisor<\/a>, Medtronic PLC has a &#8220;Neutral&#8221; rating, based on eight positive and seven negative signals. The stock&#8217;s recent performance shows a 3.63% increase over the past week and a 5.34% rise over the past month. The average analyst target price for Medtronic over the next 12 months is $89.10, with ratings ranging from &#8220;Sell&#8221; to &#8220;Hold&#8221; by various analysts. The stock is currently trading at $84.82.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Positive aspects of Medtronic&#8217;s stock include its high market capitalization, low volatility, and superior total returns compared to its sector peers. However, there are concerns about its poor risk-adjusted returns, high leverage, and low revenue and dividend growth over the past five years.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Should I Buy Medtronic PLC Stock?<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">Investing in Medtronic PLC presents a balanced risk-reward scenario. On the one hand, the company&#8217;s strong Q1 performance, driven by product innovation and strategic market positioning, indicates potential for sustained growth. The raised FY25 guidance further underscores management&#8217;s confidence in future earnings. Additionally, Medtronic&#8217;s ability to deliver positive cash flow and maintain high returns on assets and equity are encouraging signs for investors.<\/span><\/p>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/pricing\"><img decoding=\"async\" class=\"aligncenter wp-image-48710 size-full\" src=\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2024\/05\/CTA-for-STA.jpg\" alt=\"CTA for STA\" width=\"1200\" height=\"350\" srcset=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/05\/CTA-for-STA.jpg 1200w, https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/05\/CTA-for-STA-300x88.jpg 300w, https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/05\/CTA-for-STA-1024x299.jpg 1024w, https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/05\/CTA-for-STA-150x44.jpg 150w, https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/05\/CTA-for-STA-768x224.jpg 768w\" sizes=\"(max-width: 709px) 85vw, (max-width: 909px) 67vw, (max-width: 1362px) 62vw, 840px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">However, potential investors should be cautious of the stock&#8217;s current valuation. Medtronic is trading at a relatively high price-to-earnings (P\/E) ratio of 29.62, which might limit upside potential unless the company continues to outperform expectations. The high debt levels and below-median dividend and revenue growth also suggest that the stock may face challenges in delivering consistent returns.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Conclusion:\u00a0<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">Medtronic&#8217;s Q1 FY25 results reflect a company in a strong position, leveraging its innovative product offerings to drive growth. As always, potential investors should weigh these factors carefully in the context of their individual investment goals and risk tolerance.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medtronic PLC (MDT), a global leader in healthcare technology, recently released its first-quarter financial results for fiscal year 2025 (FY25). The company reported promising growth,&#8230;<\/p>\n","protected":false},"author":17,"featured_media":53228,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-53225","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches\" \/>\n<meta property=\"og:description\" content=\"Medtronic PLC (MDT), a global leader in healthcare technology, recently released its first-quarter financial results for fiscal year 2025 (FY25). The company reported promising growth,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-20T13:49:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/08\/STAs-Blog-Images-2024-08-20T184835.073.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Muzzammil Ahmad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/x.com\/Muzzammil625\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Muzzammil Ahmad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\"},\"author\":{\"name\":\"Muzzammil Ahmad\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\"},\"headline\":\"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches\",\"datePublished\":\"2024-08-20T13:49:45+00:00\",\"dateModified\":\"2024-08-20T13:49:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\"},\"wordCount\":432,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\",\"name\":\"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-08-20T13:49:45+00:00\",\"dateModified\":\"2024-08-20T13:49:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\",\"name\":\"Muzzammil Ahmad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"caption\":\"Muzzammil Ahmad\"},\"description\":\"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/\",\"https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625\"],\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/","og_locale":"en_US","og_type":"article","og_title":"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches","og_description":"Medtronic PLC (MDT), a global leader in healthcare technology, recently released its first-quarter financial results for fiscal year 2025 (FY25). The company reported promising growth,...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-08-20T13:49:45+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/08\/STAs-Blog-Images-2024-08-20T184835.073.jpg","type":"image\/jpeg"}],"author":"Muzzammil Ahmad","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/x.com\/Muzzammil625","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Muzzammil Ahmad","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/"},"author":{"name":"Muzzammil Ahmad","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8"},"headline":"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches","datePublished":"2024-08-20T13:49:45+00:00","dateModified":"2024-08-20T13:49:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/"},"wordCount":432,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/","name":"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-08-20T13:49:45+00:00","dateModified":"2024-08-20T13:49:45+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/medtronics-q1-fy25-highlights-strong-revenue-growth-and-successful-product-launches\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Medtronic\u2019s Q1 FY25 Highlights: Strong Revenue Growth and Successful Product Launches"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8","name":"Muzzammil Ahmad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","caption":"Muzzammil Ahmad"},"description":"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.","sameAs":["https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/","https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625"],"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/53225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=53225"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/53225\/revisions"}],"predecessor-version":[{"id":53229,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/53225\/revisions\/53229"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/53228"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=53225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=53225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=53225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}